Class IIITerminatedD-0454-2023
Drug recall · March 15, 2023
DIBUCAINE 1% HEMORRHOIDAL OINTMENT recall
Why: Labeling: Incorrect or Missing Lot and/or Exp Date
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1
- Lots / codes
Lot #: 2206016, Exp. date 05/2024
- Quantity
- 4,416 tubes
- Company
- Akron Pharma, Inc., Fairfield, NJ
- Distribution
- Nationwide within the United States
- Initiated
- February 17, 2023 · Voluntary: Firm initiated
- Classified
- March 9, 2023
- Reported
- March 15, 2023
- Ended
- September 9, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dibucaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.